PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by Adpathway
Ljupco/iStock via Getty Images
Eli Lilly (LLY) on Saturday reported positive results from two late-stage clinical trials of its experimental obesity drug retatrutide, showing substantial weight loss along with improvements in type 2 diabetes, knee osteoarthritis pain and obstructive sleep apnea.
The results, presented at
























English (US) ·
French (CA) ·
French (FR) ·